#ZLAB
grey butcherbird singing, this is what they sound like in Sydney
www.youtube.com/watch?v=ZlAb...
GREY BUTCHERBIRD SONGS
YouTube video by Pittwater Ecowarriors
www.youtube.com
November 12, 2026 at 3:06 AM
Zai Lab ($ZLAB) – Insider Purchase

• Insider: Richard Gaynor, Director
• Bought: 1,228 shares (about $33K)
• Price: about $27.19 a share · Nov 10
• Now Holds: 81,965 shares directly

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#InsiderBuying #Stocks
Richard Gaynor (Director) bought $33K of Zai Lab ($ZLAB)
Form 4 filed Nov 13. Every line of the filing.
elixstocks.com
November 14, 2026 at 11:18 AM
#ZLAB Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, E…

https://www.stocktitan.net/news/ZLAB/zai-lab-announces-first-time-inclusion-of-kar-xt-and-vyvgart-hytrulo-634man01ervk.html?utm_source=stocktitan-bluesky&utm_medium=social
Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) secured inclusion of five commercial medicines in China’s 2026 National Reimbursement Drug List, effective January 1, 2027.KarXT and VYVGART Hytrulo received first-time listings for adult schizophrenia and adult anti-acetylcholine receptor antibody-positive generalized myasthenia gravis, respectively. The latter is an autoimmune condition causing muscle weakness. Reimbursement listings were renewed for NUZYRA for specified bacterial infections, QINLOCK for previously treated advanced gastrointestinal stromal tumors, and AUGTYRO for specified lung cancers and gene fusion-positive solid tumors. Zai Lab expects the new listings to broaden patient access.
www.stocktitan.net
November 14, 2026 at 3:26 AM
BBBB zlAB B B BBBBzlA B BBB zlA zlY Y zlY zlaA B↓ B
BBBB zlAB B B BBBBzlA B BBB zlA zlY Y zlY zla B↓ B
lX↑ zlY↑ Y↑Y↑ zlY↑zlY↑zlY↑ zlX↑ Y↑ zlY↑ zlY zlY↑ B B↓ B
zlY↑zlY↑ zlYzlY zlY↓ zlYzlYzlY zlY↓ B

何とは言いませんが、おすすめはしません
November 10, 2026 at 11:31 AM
Zai Lab: Q3 revenue $108.2M, net loss $46.1M, cash $559.7M; povetacicept PDUFA Nov 30; zoci Phase 3 start targeted YE 2026.

#$ZLAB FAQ + PDF report: www.merlintrader.com/zai-lab-stoc...
ZLAB Stock: Zai Lab News, Zoci & Regional Medicines
Zai Lab stock news and analysis: Zoci early lung-cancer evidence, China commercial products, regional rights, resources and restricted cash for ZLAB holders.
www.merlintrader.com
November 5, 2026 at 6:15 PM
Zai Lab $ZLAB reported Q3 2026 EPS of -$0.04, beating the -$0.58 estimate by 93.1%. Revenue of $108.2M beat the $107.9M estimate by 0.3%.

https://fundspec.ai/s/ZLAB/earnings
See the option sweeps hedge funds are loading up on, in real time.
November 5, 2026 at 11:36 AM
🚨 $ZLAB
On November 5, 2026, Zai Lab Limited issued a press release announcing its financial results for the third quarter of 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
SEC Filing: ZLAB
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 11:37 AM
#$ZLAB Q3 2026 results call: Thu Nov 5, 8:00 a.m. ET. Close $22.36 (Oct 29), RSI 41, 20d range $21.60-$26.92.
zailab.gcs-web.com/events/event...
www.merlintrader.com/zai-lab-stoc...
October 30, 2026 at 2:30 PM
#$ZLAB Q3 2026 results call: Thu Nov 5, 8:00 a.m. ET. Close $22.36 (Oct 29), RSI 41, 20d range $21.60-$26.92.
zailab.gcs-web.com/events/event...
www.merlintrader.com/zai-lab-stoc...
October 30, 2026 at 2:30 PM
#$ZLAB jumped 9.0% to $24.03, just under the 50-day EMA ($24.20) and above the 200-day ($23.05), in the middle of a 20-day range of $21.60-$26.92. Daily RSI 48.

Interactive chart at JC Just Charts: justcharts.merlintrader.com#ZLAB
Not investment advice.
JustCharts: Stock Charts & Technical Analysis | Merlintrader
Explore US stock charts with EMA 50 and 200, support, resistance, trendlines and conditional technical scenarios. Daily data from the Merlintrader hub universe.
justcharts.merlintrader.com
October 25, 2026 at 9:43 PM
🚨 $ZLAB
On October 23, 2026, the Company published an updated corporate presentation.
SEC Filing: ZLAB
Click to view the official SEC document.
www.sec.gov
October 23, 2026 at 10:07 AM
#$ZLAB: Phase 1b trial of ZLAB's zoci plus atezolizumab showed 81.8% response rate and durable benefit in first-line small cell lung cancer. Shares opened 5% higher.
October 23, 2026 at 2:05 PM
$ZLAB Oct 23, 2026: An updated corporate presentation (8-K) shows first-line extensive-stage SCLC data for zoci: 27 of 33 patients (81.8%) had a confirmed response with zoci 1.6 mg/kg plus atezolizumab, no chemo.

https://www.merlintrader.com/zai-lab-stock-hub/
Zai Lab $ZLAB Stock: Povetacicept PDUFA, Zoci & Risks
Zai Lab stock analysis: November povetacicept PDUFA, regional rights, Zoci at ESMO, China sales, restricted cash, debt and ADS valuation risks.
www.merlintrader.com
October 23, 2026 at 12:00 PM
$LNAI to delist from NASDAQ after equity shortfall; trading ends Oct 30. No OTC plans, SEC reporting ends, CFO/board resign. Liquidity constrained. $LNAI $LUCD $ZLAB $EVAX $AARD

www.biopharmcatalyst.com/news/2026/bi...
Pre-Market Updates 10/23/26
export-download.canva.com
October 23, 2026 at 12:40 PM
$ZLAB Latest company news, Oct 22, 2026: Zai Lab is raising about $250M in a private placement: 11.34M ADSs at $22.04, led by TCGX, with RA Capital, RTW, Wellington and other new and existing investors.

https://www.merlintrader.com/zai-lab-stock-hub/
Zai Lab $ZLAB Stock: Povetacicept PDUFA, Zoci & Risks
Zai Lab stock analysis: November povetacicept PDUFA, regional rights, Zoci at ESMO, China sales, restricted cash, debt and ADS valuation risks.
www.merlintrader.com
October 23, 2026 at 8:36 AM
📅 CATALYST REMINDER | #$ZLAB
October 26, 2026 — Investor Webcast & Phase 1 Data
Oct 23: ESMO investor webcast on zocilurtatug pelitecan (8:00 a.m. ET). Oct 26: Phase 1 first-line ES-SCLC poster at ESMO.
🔗 Full details: www.merlintrader.com/zai-lab-stoc...
#ZLAB #Biotech #ESMO2026
October 17, 2026 at 7:14 PM
Latest company news, September 29, 2026: Zai Lab will present the first global zoci data at ESMO, with a webcast on October 23 and a poster on October 26.

https://www.merlintrader.com/zai-lab-stock-hub/
Zai Lab $ZLAB Stock: Povetacicept PDUFA, Zoci & Risks
Zai Lab stock analysis: November povetacicept PDUFA, regional rights, Zoci at ESMO, China sales, restricted cash, debt and ADS valuation risks.
www.merlintrader.com
October 9, 2026 at 11:10 AM
Spoilers for FFXIV Endwalker !
.
.
.
I love and hate that these comments on this video are technically true 🤣🤣🤣

m.youtube.com/watch?v=ZlAb...
October 8, 2026 at 8:03 AM